Drugs / GK02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07378436 | Sep 2025 → Dec 2026 expected | peritoneal neoplasm | Beijing Geekgene Technology Co., LTD | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GK02 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07378436 ↗ |